340 related articles for article (PubMed ID: 26324998)
1. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
[TBL] [Abstract][Full Text] [Related]
2. Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice.
Szyszko EA; Skarstein K; Jonsson R; Brokstad KA
Autoimmunity; 2011 Aug; 44(5):415-26. PubMed ID: 21332424
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
4. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
7. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
9. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
10. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
11. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival.
Szyszko EA; Brokstad KA; Oijordsbakken G; Jonsson MV; Jonsson R; Skarstein K
Arthritis Res Ther; 2011 Jan; 13(1):R2. PubMed ID: 21214903
[TBL] [Abstract][Full Text] [Related]
12. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
13. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
14. Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome.
Kiripolsky J; Romano RA; Kasperek EM; Yu G; Kramer JM
Front Immunol; 2019; 10():2963. PubMed ID: 31993047
[TBL] [Abstract][Full Text] [Related]
15. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
[TBL] [Abstract][Full Text] [Related]
16. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
17. Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2
Kiripolsky J; Shen L; Liang Y; Li A; Suresh L; Lian Y; Li QZ; Gaile DP; Kramer JM
Clin Immunol; 2017 Oct; 183():225-232. PubMed ID: 28526333
[TBL] [Abstract][Full Text] [Related]
18. Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Brokstad KA; Jakobsen K; Jonsson R; Skarstein K
Autoimmunity; 2012 Nov; 45(7):547-55. PubMed ID: 22849322
[TBL] [Abstract][Full Text] [Related]
19. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
20. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
